Details for 2019752609

Up to date per 04.04.2026

Actions

Title / Product Name

SULFOPROPANSÄUREDERIVATE ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019752609

EP Publication Number

3829568

E-Number

1607589

Language

PCT Number

US19044114

Publication Date

09.06.2021 A

06.09.2023 B1

Registration Date

06.09.2023

AT Publication Date

15.09.2023

Application Date

30.07.2019

Registration Number

Priorities

01.08.2018

201862713056 P

IPC

A61K 31/221 20060101AFI20200207BHEP

Maximum Duration of Protection

30.07.2039

Owner

Alzheon, Inc.111 Speen Street Suite 306 Framingham, MA 01701US

Representative

Dipl.-Ing. Werner Barger, Dipl.-Ing. Dr. techn. Peter IsrailoffOperngasse 41010 WienAT

Inventor

KOCIS, Petr111 Speen Street, Suite 306 Framingham, MA 01701US

HEY, John111 Speen Street, Suite 306 Framingham, MA 01701US

TOLAR, Martin111 Speen Street, Suite 306 Framingham, MA 01701US

Information about Fees